Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 2/20 | 0.44 |
| ▸ | FNTA | P49354 | 9/20 | 0.43 |
| ▸ | FNTB | P49356 | 9/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 7/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | ARG1 | P05089 | 1/20 | 0.39 |
| ▸ | ARG2 | P78540 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.37 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12257898 | 0.83 | CTSC (0.45) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL12341594 | 0.83 | CTSC (0.45) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL17746783 | 0.80 | SLC15A1 (0.48) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL10979752 | 0.80 | CTSC (0.43) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL538055 | 0.80 | ALDH1A1 (0.44) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL10607119 | 0.80 | CTSC (0.43) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL538056 | 0.80 | ALDH1A1 (0.44) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL10607116 | 0.80 | CTSC (0.43) | CTSCFNTAFNTBPGGT1BDPP7 | |
| SCHEMBL21983542 | 0.79 | ANPEP (0.50) | CTSCFNTAFNTBPGGT1BDPP7 | |
| Hydrochloric Acid SCHEMBL28446972 | 0.79 | ALDH1A1 (0.43) | CTSCFNTAFNTBPGGT1BDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | APICAL MOLECULAR BIOTECH CO., LTD. (TW) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | FABP1, GLS2, SLC1A5 | CTSC 1169/4885FNTA 445/4885FNTB 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.